Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gefapixant citrate is an orally active P2X3 receptor (P2X3R) antagonist that acts on human homologous recombinant hP2X3 (IC50: ~30 nM) and hP2X2/3 (IC50: 100-200 nM). gefapixant citrate can be used to study chronic cough and knee osteoarthritis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 6-8 weeks | $ 58.00 | |
50 mg | 6-8 weeks | $ 238.00 | |
100 mg | 6-8 weeks | $ 428.00 |
Description | Gefapixant citrate is an orally active P2X3 receptor (P2X3R) antagonist that acts on human homologous recombinant hP2X3 (IC50: ~30 nM) and hP2X2/3 (IC50: 100-200 nM). gefapixant citrate can be used to study chronic cough and knee osteoarthritis. |
Molecular Weight | 545.52 |
Formula | C20H27N5O11S |
CAS No. | 2310299-91-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gefapixant citrate 2310299-91-1 inhibitor inhibit